Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Vaneck Pharmaceutical ETF (PPH)

Vaneck Pharmaceutical ETF (PPH)
89.09 x 28 91.50 x 11
Post-market by (Cboe BZX)
91.26 +0.92 (+1.02%) 02/21/25 [NASDAQ]
89.09 x 28 91.50 x 11
Post-market 91.50 +0.24 (+0.26%) 19:46 ET
Quote Overview for Fri, Feb 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
90.51
Day High
91.48
Open 90.61
Previous Close 90.34 90.34
Volume 1,341,400 1,341,400
Avg Vol 414,470 414,470
Stochastic %K 83.58% 83.58%
Weighted Alpha +0.86 +0.86
5-Day Change +1.83 (+2.05%) +1.83 (+2.05%)
52-Week Range 84.48 - 99.51 84.48 - 99.51
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 569,462,400
  • Shares Outstanding, K 6,240
  • 60-Month Beta 0.72
  • Price/Earnings ttm 15.43
  • Annual Dividend & Yield 1.71 (1.87%)
  • Most Recent Dividend 0.411 on 12/27/24
  • Management Fee 0.36%
  • INDUSTRY GROUPING:

    ETFs - Healthcare

Options Overview Details

View History
  • Implied Volatility 14.25% ( +1.88%)
  • Historical Volatility 15.39%
  • IV Percentile 68%
  • IV Rank 34.58%
  • IV High 23.15% on 08/05/24
  • IV Low 9.54% on 11/13/24
  • Put/Call Vol Ratio 1.20
  • Today's Volume 112
  • Volume Avg (30-Day) 168
  • Put/Call OI Ratio 7.24
  • Today's Open Interest 4,334
  • Open Int (30-Day) 3,602

Price Performance

See More
Period Period Low Period High Performance
1-Month
85.49 +6.75%
on 01/22/25
Period Open: 86.27
91.48 -0.24%
on 02/21/25
+4.99 (+5.78%)
since 01/21/25
3-Month
84.48 +8.03%
on 01/14/25
Period Open: 87.94
91.48 -0.24%
on 02/21/25
+3.32 (+3.78%)
since 11/21/24
52-Week
84.48 +8.03%
on 01/14/25
Period Open: 89.00
99.51 -8.29%
on 09/03/24
+2.26 (+2.54%)
since 02/21/24

Most Recent Stories

More News
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises

The company’s Solta segment, which includes medical aesthetics, saw Q4 revenue climb 34% to $138 million, fueled by strong demand in South Korea and China.

VSS : 117.62 (-1.18%)
VXUS : 62.83 (-0.65%)
PPH : 91.26 (+1.02%)
BLCO : 15.75 (-0.88%)
BHC : 7.31 (+1.81%)
Cencora Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Cencora's underperformance relative to the broader market over the past year, Wall Street analysts remain bullish on the stock's future.

$SPX : 6,013.13 (-1.71%)
COR : 241.43 (-0.83%)
PPH : 91.26 (+1.02%)
Is Wall Street Bullish or Bearish on AbbVie Stock?

Despite AbbVie's underperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock's future.

$SPX : 6,013.13 (-1.71%)
PPH : 91.26 (+1.02%)
ABBV : 202.08 (+0.60%)
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip

Eli Lilly and Company LLY dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than-expected sales for its weight-loss medicine...

OZEM : 25.88 (+1.09%)
IHE : 71.54 (+0.58%)
LLY : 873.68 (+0.06%)
MEDX : 28.39 (+0.24%)
PPH : 91.26 (+1.02%)
THNR : 23.23 (+0.61%)
Winners and Losers: Post-Election Options Analysis

Investors are anticipating which sectors might be most affected by the Trump administration. Brett Friedman, Winhall Risk Analytics/OptionMetrics Contributor takes a look at options data and implied volatility...

XLE : 90.93 (-2.08%)
ITA : 149.35 (-2.33%)
PPH : 91.26 (+1.02%)
^BTCUSD : 96,568.00 (+1.28%)
Are Wall Street Analysts Predicting Cencora Stock Will Climb or Sink?

Cencora has underperformed the broader market over the past year, and Wall Street analysts appear moderately bullish about the stock’s future.

HON : 211.94 (+0.28%)
$SPX : 6,013.13 (-1.71%)
COR : 241.43 (-0.83%)
PPH : 91.26 (+1.02%)
Stocks and ETFs in Focus as Americans Head to Polls

Election Day has approached, and the polls indicate a tight race between Democratic Party candidate Kamala Harris and Republican nominee Donald Trump. Neither candidate holds a meaningful edge in enough...

KBWB : 68.94 (-1.84%)
BE : 24.17 (-7.00%)
CVX : 156.92 (-1.18%)
JPM : 264.24 (-0.96%)
MRK : 89.50 (+2.08%)
IHE : 71.54 (+0.58%)
PPH : 91.26 (+1.02%)
UNH : 466.42 (-7.17%)
PFE : 26.30 (+1.54%)
KBH : 61.26 (-2.50%)
XLE : 90.93 (-2.08%)
XHB : 101.11 (-2.75%)
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike

Johnson & Johnson JNJ infused positive optimism for the broader healthcare sector after posting solid third-quarter 2024 earnings on Oct. 15. The world's biggest healthcare products maker continued with...

XLV : 146.43 (-0.54%)
JNJ : 162.30 (+1.64%)
IHE : 71.54 (+0.58%)
IYH : 61.56 (-0.55%)
PPH : 91.26 (+1.02%)
FTXH : 27.99 (+0.43%)
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR

For Immediate ReleaseChicago, IL – October 17, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

NVO : 88.08 (+5.18%)
LLY : 873.68 (+0.06%)
HRTS : 30.72 (-0.07%)
PPH : 91.26 (+1.02%)
THNR : 23.23 (+0.61%)
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win

In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications, particularly GLP-1 receptor agonists such as Ozempic and Wegovy. The global...

NVO : 88.08 (+5.18%)
LLY : 873.68 (+0.06%)
HRTS : 30.72 (-0.07%)
PPH : 91.26 (+1.02%)
THNR : 23.23 (+0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Fund Summary

The VanEck Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical...

See More

Key Turning Points

3rd Resistance Point 92.63
2nd Resistance Point 92.05
1st Resistance Point 91.66
Last Price 91.26
1st Support Level 90.69
2nd Support Level 90.11
3rd Support Level 89.72

See More

52-Week High 99.51
Fibonacci 61.8% 93.77
Fibonacci 50% 91.99
Last Price 91.26
Fibonacci 38.2% 90.22
52-Week Low 84.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements